Details
- Close date
- No date set
- Academic background
- Health Sciences
- Host campus
- Dunedin
- Qualification
- Master's, Honours
- Department
- Pathology (Dunedin)
- Supervisor
- Dr Glen Reid
Overview
Nucleic acid-based drugs have the potential to be used as therapy to inhibit undruggable targets including proteins and RNAs. Examples include siRNAs, antisense oligonucleotides and microRNA mimics.
This project will investigate the activity of novel dual-action silencing constructs on the biology and drug sensitivity of non-small cell lung cancer (NSCLC) and mesothelioma cell lines, by combining microRNA replacement, siRNA-mediated oncogene knockdown, and antisense inhibition.
Useful information
Similar research opportunities
- A phoenix from the ashes: Do dying cancer cells induce drug-tolerance in lung cancer?
- A role for untranslated p53 mRNA in drug resistance
- Characterisation of YB-1 interactions with the cytoskeleton using live cell imaging
- Characteristion of YB-1 interactions with the cytoskeleton using live cell imaging
- Comprehensive characterization of uncommon TP53 mutations in cancer